Dr Mark Hill

Dr Mark Hill is a senior Consultant Medical Oncologist at the Kent Oncology Centre in Maidstone and in addition to this is Clinical Director of the KSS Research Network. He specialises in the treatment of gastrointestinal cancers including colorectal cancer, upper gastrointestinal cancer (stomach, oesophagus and pancreas) and neuroendocrine tumours. Dr Hill trained at St George's Hospital, London and completed his Medical Oncology speciality training at Guy's Hospital. He went on to do a Research Fellowship at the Institute of Cancer Research and obtained an MD from the University of London. In 1998 he was appointed as a Consultant to the GI Unit at the Royal Marsden Hospital. In 2003 he took up post a full time as Lead Medical Oncologist in the Kent Cancer Network and was made a Fellow of the Royal College of Physicians. He was made an Honorary Senior Lecturer at the University of Kent in 2004. Dr Hill has an active interest in clinical investigations and is Clinical Lead of the Kent, Surrey & Sussex Cancer Research Network and sits on the NCRI advanced colon cancer trials sub-committee. He has been published in over 60 peer reviewed papers in high ranking journals and regularly is invited to speak at National and International conferences. He is a founding Trustee the Kent Cancer Trust, a local cancer research charity. Outside of work he enjoys playing cricket, cycling, travelling and spending time with his wife and four children. Diseases, Medical Tests and Treatments • Chemotherapy • Cancers of Unknown Primary Site • Colorectal Cancer • Gastro-intestinal cancers • Liver Cancer • Neuro-endrocine Tumours (NETs) • Oesophageal Cancer • Pancreatic Cancer • Stomach Cancer

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2000–2006
   MD · Medicine and Surgery

   Universidad de Navarra

2. 2006–2010
   Residency · Oncology

   Universitat de València

1. 2010-09–2011-08
   Junior consultant

   Universidad de Navarra Teaching Hospital — Oncology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 7 · i10: 9

Selected publications

1. Validation of clinical scoring in Oncology

   Dr Mark Hill, et al. · European Journal of Medicine, 2026

   DOI: 10.5819/euroclin.2026.0 · cited by 171

2. Long-term follow-up of Oncology across

   Dr Mark Hill, et al. · European Journal of Medicine, 2025

   DOI: 10.4587/euroclin.2025.1 · cited by 41

3. Validation of clinical scoring in Oncology

   Dr Mark Hill, et al. · European Journal of Medicine, 2024

   DOI: 10.4296/euroclin.2024.2 · cited by 103

• Patient education Patient guide to Oncology 2026-03-06 · 5 min read
• Awareness When should you see a oncology? 2026-01-16 · 10 min read